Interview today: #COVID19 Vaccine Prospects &amp; Pipeline Update
- Major players' clinical progress &amp; potential winner 
- Ease of manufacturing &amp; scalability 
- Pricing dynamics &amp; other commercial pain points 
Related: $MRNA $JNJ $PFE
https://t.co/V2wLAbzFjB